Option Care Health (MM6A) Price & Analysis

Compare

0 Followers

MM6A Stock Chart & Stats

€26.00

€0.00(0.00%)

At close: Jan 08 4:00 PM EST

€26.00

€0.00(0.00%)

Day’s Range― - ―

52-Week Range€22.20 - €32.40

Previous CloseN/A

Volume0.00

Average Volume (3M)0.00

Market Cap

€3.94B

Enterprise Value€4.28B

Total Cash (Recent Filing)€232.62M

Total Debt (Recent Filing)€0.00

Price to Earnings (P/E)24.3

Beta0.60

Next Earnings

Apr 29, 2026

EPS Estimate

0.33

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.40

Shares Outstanding156,447,970

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio5.98

Price to Book (P/B)3.80

Price to Sales (P/S)0.89

P/FCF Ratio19.51

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€34.67

Price Target Upside33.36% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering12

EPS Forecast (FY)1.62

Revenue Forecast (FY)€5.16B

Bulls Say, Bears Say

Bulls Say

Capital AllocationBoard approval of a larger share repurchase authorization signals management confidence in cash flow and supports future buybacks and selective acquisitions that can enhance shareholder returns.

Demand DriversAn aging population and a shift to lower-cost care settings underpin demand for infusion and home healthcare services and support continued market share growth.

Portfolio DiversificationReduced reliance on a single therapy materially lowers concentration risk and positions the product portfolio to support renewed revenue growth and margin expansion.

Bears Say

Margin Pressure From Operating CostsOperating expenses are expected to grow in line with or faster than gross profit, which may limit margin expansion despite revenue gains.

Pricing And Biosimilar CompetitionPricing pressure from biosimilars and changes in reimbursement policy for a major therapy is expected to reduce gross profit and put downward pressure on margins.

Revenue Comparability And Cash FlowTougher year-over-year comparisons after prior inventory restocking could soften revenue growth and cash flow from operations may remain pressured, constraining financial flexibility.

Option Care Health News

Option Care Health price target raised to $38 from $36 at Deutsche Bank

Deutsche Bank raised the firm’s price target on Option Care Health (OPCH) to $38 from $36 and keeps...

25d ago

OPCH

Option Care Health reports Q4 adjusted EPS 46c, consensus 47c

Reports Q4 revenue $1.46B, consensus $1.46B. John Rademacher, Chief Executive Officer, commented, “Our team continued to execute at...

26d ago

OPCH

Option Care Health sees FY26 adjusted EPS $1.82-$1.92, consensus $1.87

Sees FY26 adjusted EBITDA of $480 million to $505 million Published first on TheFly – the ultimate source...

26d ago

OPCH

Option Care Health Balances Growth With 2026 Headwinds

Option Care Health Inc (($OPCH)) has held its Q4 earnings call. Read on for the main highlights of...

24d ago

OPCH

Buy Rating Maintained as Stelara Headwind Fades and Core Profitability Remains Stable

Analyst Erin Wright from Morgan Stanley maintained a Buy rating on Option Care Health and keeping the price...

25d ago

OPCH

OPCH Upcoming Earnings Report: What to Expect?

Option Care Health Inc (OPCH) is scheduled to report 4th quarter earnings on 02/24/2026, before the market opens....

28d ago

OPCH

Option Care Health price target raised to $37 from $27 at TD Cowen

TD Cowen raised the firm’s price target on Option Care Health (OPCH) to $37 from $27 and keeps...

2M ago

OPCH

Option Care Health price target raised to $42 from $38 at Barrington

Barrington analyst Michael Petusky raised the firm’s price target on Option Care Health (OPCH) to $42 from $38...

2M ago

OPCH

Option Care Health: Resilient Core Growth, Structural Tailwinds, and Capital Allocation Support Buy Rating

In a report released today, Joanna Gajuk from Bank of America Securities reiterated a Buy rating on Option...

2M ago

OPCH

Option Care Health price target raised to $38 from $36 at Citizens

Citizens raised the firm’s price target on Option Care Health (OPCH) to $38 from $36 and keeps an...

2M ago

OPCH

Closing Bell Movers: Revvity up 9% on strong outlook

Escalating tensions between the White House and the Federal Reserve – whereby an investigation of Powell over his...

2M ago

DAL

Option Care Health Issues 2025 Results and 2026 Outlook

Option Care Health ( ($OPCH) ) just unveiled an announcement. On January 12, 2026, Option Care Health released...

2M ago

OPCH

Option Care Health raises FY25 adjusted EPS view to $1.72-$1.76 from $1.68-$1.72

Consensus $1.72. Raises FY25 revenue view to $5.65B-$5.66B from $5.6B-$5.65B, consensus $5.64B. Narrows FY26 adjusted EBITDA view to...

2M ago

OPCH

Option Care Health sees FY26 adjusted EPS $1.82-$1.92, consensus $1.88

Sees FY26 revenue $5.8B-$6B, consensus $6.06B. Sees FY26 adjusted EBITDA $480M-$505M. Published first on TheFly – the ultimate...

2M ago

OPCH

MM6A FAQ

What was Option Care Health’s price range in the past 12 months?

Option Care Health lowest stock price was €22.20 and its highest was €32.40 in the past 12 months.

What is Option Care Health’s market cap?

Option Care Health’s market cap is €3.94B.

When is Option Care Health’s upcoming earnings report date?

Option Care Health’s upcoming earnings report date is Apr 29, 2026 which is in 38 days.

How were Option Care Health’s earnings last quarter?

Option Care Health released its earnings results on Feb 24, 2026. The company reported €0.399 earnings per share for the quarter, missing the consensus estimate of €0.407 by -€0.008.

Is Option Care Health overvalued?

According to Wall Street analysts Option Care Health’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Option Care Health pay dividends?

Option Care Health does not currently pay dividends.

What is Option Care Health’s EPS estimate?

Option Care Health’s EPS estimate is 0.33.

How many shares outstanding does Option Care Health have?

Option Care Health has 156,447,970 shares outstanding.

What happened to Option Care Health’s price movement after its last earnings report?

Option Care Health reported an EPS of €0.399 in its last earnings report, missing expectations of €0.407. Following the earnings report the stock price went up 1.351%.

Which hedge fund is a major shareholder of Option Care Health?

Currently, no hedge funds are holding shares in DE:MM6A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Option Care Health Stock Smart Score

Outperform

Fundamentals

Return on Equity

15.39%

Trailing 12-Months

Asset Growth

0.81%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Option Care Health

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Option Care Health (MM6A) Earnings & Revenues

Historic Earnings Reports

MM6A Earnings Call

Q4 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call conveys a constructive operational and financial story: strong top-line growth, margin and automation gains, successful clinic and M&A integration, expanded pharma and payer partnerships, and a reaffirmation of 2026 guidance. Key near-term challenges include Stelara biosimilar-driven revenue and gross profit headwinds, a 2025 cash flow shortfall due to strategic inventory buys and elevated working capital needs, and persistent payer/market pressure. Management outlined concrete efficiency and cash-conversion actions and expects cash flow and EBITDA expansion in 2026, indicating confidence that headwinds are manageable.View all DE:MM6A earnings summaries

MM6A Stock 12 Month Forecast

Average Price Target

€34.67

▲(33.36% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"21":"€21","30":"€30","39":"€39","25.5":"€25.5","34.5":"€34.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":38.91148155,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€38.91</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.674453559,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€34.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":31.99388483,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€31.99</span>\n  </div></div>","useHTML":true}}],"tickPositions":[21,25.5,30,34.5,39],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27,27.91626781153846,28.83253562307692,29.748803434615382,30.665071246153847,31.581339057692308,32.497606869230765,33.413874680769226,34.330142492307694,35.246410303846154,36.162678115384615,37.078945926923076,37.99521373846154,{"y":38.91148155,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27,27.590342581461538,28.180685162923076,28.771027744384615,29.361370325846153,29.95171290730769,30.54205548876923,31.13239807023077,31.722740651692305,32.31308323315385,32.90342581461538,33.49376839607692,34.08411097753846,{"y":34.674453559,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27,27.384144986923076,27.768289973846155,28.15243496076923,28.536579947692307,28.920724934615386,29.30486992153846,29.689014908461537,30.073159895384613,30.457304882307692,30.841449869230768,31.225594856153847,31.609739843076923,{"y":31.99388483,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":31.4,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":32,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.8,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.2,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.8,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.8,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":26.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":28,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":27,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >